Skip to main content
. 2019 Nov 5;29(6):1621–1632.e3. doi: 10.1016/j.celrep.2019.09.074

Figure 7.

Figure 7

M12 Residue, Found Specifically in HLA-A68:02, Promotes Its Accessibility to TAPBPR

(A) PyMOL figures highlighting amino acid differences between A68:02 and A68:01 (left), A69:01 (center), and A02:01 (right), respectively; conserved residues are colored in blue, different residues between A68:02 and A68:01 in red, and differences between A68:02 and other strong binders in green.

(B) Histograms showing cell surface levels of A68:02WT, A68:02M12V, A68:02P105S, A02:01WT, A02:01V12M, and A02:01S105P.

(C) Histograms show TAPBPR binding to the HLA I variants in (B), after cells were treated with 100 nM TAPBPR for 30 min.

(D) Bar graphs showing TAPBPR binding to the HLA I allotypes tested in (C), upon treatment with either 100 nM (light gray) or 1 μM TAPBPR (dark gray).

Bars show MFI ± SD from three independent experiments. n/s, not significant; p ≤ 0.05, ∗∗∗∗p ≤ 0.0001 using unpaired two-tailed t test.